x
Filter:
Filters applied
- Oncology
- Assel, MelissaRemove Assel, Melissa filter
Publication Date
Please choose a date range between 2018 and 2019.
Author
- Carver, Brett S2
- Sheinfeld, Joel2
- Sjoberg, Daniel D2
- Bajorin, Dean1
- Bajorin, Dean F1
- Becerra, Maria F1
- Bosl, George1
- Bosl, George J1
- Chesnut, Gregory T1
- Coleman, Jonathan A1
- Dean, Lucas W1
- Dowling, Catherine M1
- Eastham, James A1
- Ehdaie, Behfar1
- Feldman, Darren1
- Feldman, Darren R1
- Fromkin, Jillian1
- LaDuke, Emily1
- Laudone, Vincent P1
- Meeks, Joshua J1
- Motzer, Robert1
- Motzer, Robert J1
- Musser, John E1
- Pietzak, Eugene J1
Oncology
3 Results
- Oncology
Contemporary Management of Hemorrhage After Minimally Invasive Radical Prostatectomy
UrologyVol. 130p120–125Published online: April 26, 2019- Lucas W. Dean
- Amy L. Tin
- Gregory T. Chesnut
- Melissa Assel
- Emily LaDuke
- Jillian Fromkin
- and others
Cited in Scopus: 6To describe contemporary management and outcomes of patients experiencing postoperative hemorrhage after minimally invasive radical prostatectomy. - Oncology
Histologic and Oncologic Outcomes Following Liver Mass Resection With Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Germ Cell Tumor
UrologyVol. 118p114–118Published online: April 25, 2018- Eugene J. Pietzak
- Melissa Assel
- Maria F. Becerra
- Daniel Tennenbaum
- Darren R. Feldman
- Dean F. Bajorin
- and others
Cited in Scopus: 4To evaluate the oncologic outcomes and histologic concordance of postchemotherapy residual liver mass resection with postchemotherapy retroperitoneal lymph node dissection (PC-RPLND). - Oncology
Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen
UrologyVol. 114p133–138Published online: February 2, 2018- Catherine M. Dowling
- Melissa Assel
- John E. Musser
- Joshua J. Meeks
- Daniel D. Sjoberg
- George Bosl
- and others
Cited in Scopus: 8To determine the pathologic findings and clinical outcome of patients with pure embryonal carcinoma (EC) of the testis who were diagnosed with testis cancer from January 1989 to January 2013 who underwent an orchiectomy, cisplatin-based chemotherapy and a postchemotherapy retroperitoneal lymph node dissection (PC-RPLND).